Prudential Financial Inc Cytokinetics Inc Transaction History

Prudential Financial Inc

  • $70 Billion
  • Q3 2024

A detailed history of Prudential Financial Inc transactions in Cytokinetics Inc stock. As of the latest transaction made, Prudential Financial Inc holds 30,493 shares of CYTK stock, worth $1.44 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
30,493
Previous 27,635 10.34%
Holding current value
$1.44 Million
Previous $1.5 Million 7.55%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$51.22 - $60.16 $146,386 - $171,937
2,858 Added 10.34%
30,493 $1.61 Million
Q2 2024

Aug 13, 2024
SELL
$47.86 - $75.05 $377,663 - $592,219
-7,891 Reduced 22.21%
27,635 $1.5 Million
Q1 2024

May 14, 2024
SELL
$63.75 - $108.06 $4.85 Million - $8.23 Million
-76,140 Reduced 68.19%
35,526 $2.49 Million
Q4 2023

Feb 13, 2024
SELL
$26.88 - $83.49 $47,093 - $146,274
-1,752 Reduced 1.54%
111,666 $9.32 Million
Q3 2023

Nov 13, 2023
SELL
$29.46 - $36.61 $170,573 - $211,971
-5,790 Reduced 4.86%
113,418 $3.34 Million
Q2 2023

Aug 11, 2023
BUY
$32.62 - $40.75 $854,252 - $1.07 Million
26,188 Added 28.15%
119,208 $3.89 Million
Q1 2023

May 12, 2023
SELL
$33.36 - $45.71 $106,318 - $145,677
-3,187 Reduced 3.31%
93,020 $3.27 Million
Q4 2022

Feb 14, 2023
SELL
$35.77 - $51.11 $39,096 - $55,863
-1,093 Reduced 1.12%
96,207 $0
Q3 2022

Nov 04, 2022
BUY
$38.54 - $54.52 $343,661 - $486,154
8,917 Added 10.09%
97,300 $4.76 Million
Q2 2022

Aug 15, 2022
SELL
$33.93 - $48.92 $7,328 - $10,566
-216 Reduced 0.24%
88,383 $4.31 Million
Q1 2022

May 13, 2022
BUY
$29.74 - $46.0 $59 - $92
2 Added 0.0%
88,599 $3.26 Million
Q4 2021

Feb 14, 2022
SELL
$34.35 - $46.38 $21,468 - $28,987
-625 Reduced 0.7%
88,597 $3.45 Million
Q3 2021

Nov 15, 2021
BUY
$18.54 - $35.74 $222,924 - $429,737
12,024 Added 15.58%
89,222 $3.02 Million
Q2 2021

Aug 16, 2021
SELL
$19.79 - $26.99 $71,580 - $97,622
-3,617 Reduced 4.48%
77,198 $1.53 Million
Q1 2021

May 12, 2021
BUY
$18.57 - $25.68 $8,356 - $11,556
450 Added 0.56%
80,815 $1.88 Million
Q4 2020

Feb 16, 2021
SELL
$15.26 - $28.61 $812,442 - $1.52 Million
-53,240 Reduced 39.85%
80,365 $1.67 Million
Q3 2020

Nov 16, 2020
BUY
$20.58 - $28.96 $835,753 - $1.18 Million
40,610 Added 43.67%
133,605 $2.89 Million
Q2 2020

Aug 12, 2020
BUY
$11.15 - $24.64 $26,927 - $59,505
2,415 Added 2.67%
92,995 $2.19 Million
Q1 2020

May 12, 2020
SELL
$8.75 - $16.3 $8,400 - $15,648
-960 Reduced 1.05%
90,580 $1.07 Million
Q4 2019

Feb 11, 2020
BUY
$7.95 - $11.84 $1,987 - $2,960
250 Added 0.27%
91,540 $971,000
Q3 2019

Nov 13, 2019
SELL
$10.82 - $14.25 $7,357 - $9,690
-680 Reduced 0.74%
91,290 $1.04 Million
Q2 2019

Aug 08, 2019
BUY
$7.95 - $11.25 $59,307 - $83,925
7,460 Added 8.83%
91,970 $0
Q1 2019

May 15, 2019
SELL
$5.95 - $10.19 $4,403 - $7,540
-740 Reduced 0.87%
84,510 $0
Q4 2018

Feb 07, 2019
SELL
$5.91 - $9.29 $6,914 - $10,869
-1,170 Reduced 1.35%
85,250 $538,000
Q3 2018

Nov 07, 2018
BUY
$6.4 - $9.85 $19,840 - $30,535
3,100 Added 3.72%
86,420 $0
Q2 2018

Aug 13, 2018
BUY
$6.9 - $9.9 $12,075 - $17,325
1,750 Added 2.15%
83,320 $0
Q1 2018

May 04, 2018
BUY
$7.2 - $10.05 $6,336 - $8,844
880 Added 1.09%
81,570 $0
Q4 2017

Feb 13, 2018
SELL
$7.25 - $15.65 $6,235 - $13,459
-860 Reduced 1.05%
80,690 $658,000
Q3 2017

Nov 02, 2017
BUY
$12.0 - $15.0 $978,600 - $1.22 Million
81,550
81,550 $1.18 Million

Others Institutions Holding CYTK

# of Institutions
409
Shares Held
125M
Call Options Held
4.6M
Put Options Held
2.43M
View Full List

About CYTOKINETICS INC

CYTK Quotes by TradingView
  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $4.44B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track This Portfolio

Track Prudential Financial Inc Portfolio

Follow Prudential Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email